Showing results (411-420 of 492) with videos related to

Sort By:
Pageof 50
Science Translational Medicine|July 6, 2012
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's diseaseOliver Cooper, Hyemyung Seo, Shaida Andrabi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2019
Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanismsCornelis Blauwendraat, Karl Heilbron, Costanza L Vallerga, et al.
Nature Genetics|December 27, 2011
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsRosa Rademakers, Matt Baker, Alexandra M Nicholson, et al.
Annals of Neurology|November 7, 2025
Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body DiseaseMarios Gavrielatos, Michael G Heckman, Alexandra I Soto-Beasley, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
Neurobiology of Aging|July 26, 2011
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's diseaseManu Sharma, Demetrius M Maraganore, John P A Ioannidis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2024
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced DyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
Human Molecular Genetics|June 29, 2014
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodiesJose Bras, Rita Guerreiro, Lee Darwent, et al.
Neurology. Genetics|August 13, 2019
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Pageof 50